Investor Relations July 18, 2024 Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery Read More
Investor Relations July 1, 2024 Nexalin Technology Announces Closing of $5.2 Million Public Offering Read More
Investor Relations June 27, 2024 Nexalin Technology Announces Pricing of $5.2 Million Public Offering Read More
Investor Relations, Videos April 18, 2024 Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device Read More